Buy One Get One free -Llimited Time Offer X
Lexorus, a prescription drug, is manufactured in various forms such as Tablet. Increased Phosphate Levels in the Blood are some of its major therapeutic uses. Other than this, Lexorus has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Lexorus. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Some other side effects of Lexorus have been listed ahead. Usually, these side effects of Lexorus go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Lexorus is Unknown for pregnant women and Safe for women who are breastfeeding. It is important to know if Lexorus has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lexorus related warnings section.
Individuals suffering from medical conditions like Intestinal Obstruction must refrain from the use of Lexorus since this can cause severe adverse effects. Other conditions have been mentioned below in the Lexorus contraindications section.
Drug interactions for Lexorus have been reported in the medical literature. See below for a complete list.
You should also be aware that Lexorus is safe while driving, and is addiction.
Lexorus is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Based on research, the following side effects have been observed when Lexorus is used -
Severe
Moderate
Mild
Is the use of Lexorus safe for pregnant women?
No research has been done to ascertain the safety of Lexorus in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Lexorus safe during breastfeeding?
Breastfeeding women can safely use Lexorus.
What is the effect of Lexorus on the Kidneys?
Very few cases of side effects of Lexorus on kidney have been reported.
What is the effect of Lexorus on the Liver?
Information about safety of Lexorus for the liver is not available since scientific research on this is yet to be done.
What is the effect of Lexorus on the Heart?
There is no research available on the side effects of Lexorus on the heart. Therefore, its impact is unknown.
Lexorus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lexorus unless your doctor advises you to do so -
Is this Lexorus habit forming or addictive?
Lexorus is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Lexorus since it will not make you feel sleepy.
Is it safe?
Yes, Lexorus is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Lexorus for mental disorders.
Interaction between Food and Lexorus
Due to the absence of research, it is difficult to say how Lexorus and food will interact.
Interaction between Alcohol and Lexorus
Information about the interaction of Lexorus and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135